Help
Options
Didn't know it?
click below
click below
Knew it?
click below
click below
Don't Know
Remaining cards (0)
Know
retry
shuffle
restart
0:00
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
RTT - Nursing Final
| Nursing terms | Nursing definitions |
|---|---|
| Telangiectasia | chronic dilation of groups of capillaries causing elevated dark red blotches on the skin |
| Compazine | anti-emetic |
| Lomotil | anti-diarrheal |
| thrombocytosis | surplus of platelets |
| Zofran | anti-emetic |
| definitive treatment | generally accepted procedures necessary to produce a recovery in a patient |
| adjuvant | in coordination/combination with another |
| WBC count | 5,000-10,000 |
| RBC count (males) | 450,000 - 600,000 |
| RBC count (females) | 430,000 - 550,000 |
| Platelet count | 200,000 - 350,000 |
| Hematocrit (males) | 45 - 50% |
| Hematocrit (females) | 40 - 45% |
| Hemoglobin (males) | 14 - 16 g/ml |
| Hemoglobin (females) | 12 - 14 g/ml |
| vital signs | temp, pulse, respiration, BP, pain |
| Average body temperature | 98.6 |
| Normal heart rate | 60 - 100 bpm |
| Normal respiration rate | 12 - 20 breaths/minute |
| Average BP | 120/80 |
| Hypotension | systolic BP less than 90 mm/Hg |
| Orthostatic hypotension | BP lowers by 20 mm/Hg when getting up from resting position |
| Seven attributes of a symptom | Aggrevating/Alleviating factors, Location, Manifestations, Quality, Quantity, Setting, Timing |
| Methods of Physical Exam | Auscultation, Inspection, Palpation, Percussion |
| Oral Temperature | 98.6 |
| Rectal Temperature | 99.6 |
| Axillary Temperature | 97.6 |
| Tympanic Temperature | 100 |
| Severe Hypertension | 180/110 |
| Blood Count | WBC, Platelets, Hemoglobin, Hematocrit |
| Cancer patients experiencing fatigue | 72 - 99% |
| Acute skin reactions | 2 - 3 weeks after treatment starts and lasting 4 weeks after treatment ends |
| Late skin reactions | six or more months after treatment starts |
| Temporary hair loss occurs | after 2400 cGy |
| Permanent hair loss occurs | after 6000 cGy |
| Radiation necrosis occcurs | 5500 cGy or more |
| Cranial neuropathies occur | 6500 cGy or more |
| Stomatitis/Mucositis occurs | 2 - 3 weeks after treatment starts |
| Xerostomia | dry mouth |
| temporary dry mouth occurs | 1000 - 2000 cGy |
| Permanent dry mouth occurs | > 4000 cGy |
| Taste changes occur | 1000 cGy |
| Esophagitis occurs | after 2 weeks of treatment |
| Laryngitis occurs | after 2 weeks of treatment |
| Osteoradionecrosis | destruction of bone marrow affecting the bones |
| osteoradionecrosis occurs | 6 months to years after treatment |
| Trismus | constriction of the jaw muscles |
| trismus occurs | few months to years after treatment |
| moist desquamation in breast cancer occurs | 4500 - 6000 cGy |
| dry desquamation in breast cancer occurs | 3000 cGy |
| Lymphedema | accumulation of fluid in subcutaneous tissues caused by disruption in the lymphatic system |
| pneumonitis occurs | 1 - 3 months after treatment |
| Increased urinary frequency occurs | 3000 cGy |
| Adult bone tolerance level | 6000 cGy |
| Drug | any substance that alters physiologic function with the potential for affecting health |
| Medication | a drug administered for its therapeutic effects |
| 5 RIGHTS of drug safety | Patient, Medication, Dose, Route, Time |
| PRN | as needed |
| QID | 4x a day |
| BID | 2x a day |
| TID | 3x a day |
| SQ | subcutaneous injection |
| PCA | patient controlled analgesic |
| NSAIDS | non-steroidal anti-inflammatory drugs |
| IM | intramuscular |
| Analgesic | a drug that releives pain |
| Narcotic analgesics | codeine, fentanyl,dilaudid, demerol, methadone, morphine |
| anesthetic | suppresses the sensation of feeling w or w/o LOC; lidocaine |
| antibacterial | penicillin |
| antianxiety | adavan, valium, xanax |
| anticoagulants | heparin, comadin, loventox |
| anticonvulsants | dilantin, tagrotal, keppera |
| antidepressants | zoloft, prozac, ellavil |
| antiemetics | aloxi |
| antifungal | diflucan |
| antineoplastics | drugs that prevent developmental growth or proliferation of malignant cells |
| diuretics | lasix |
| hypoglycemia | metformin, glucophage |
| Biological Response Modifiers | any substance capable of altering the immune system with either a stimulatory or suppressive effect |
| sleep aids | ambien, dalmane, restoril |
| hormone therapy | megace, tamoxifen, flutamide, lupron |
| peripheral IV | short termuse of less then 72 hours |
| Extended dwell IV | 2 - 4 week time frame for use |
| Central Venous Catheter | <30 days dwell time |
| PICC | 1 year dwell time |
| Standard Precautions | assume all blood and body fluids contain germs |
| Contact Precautions | gloves, gown |
| Droplet Precautions | mask, eye protection |
| Airborne Precautions | mask |
| Special Respiratory Precautions | respirator mask |
| Full Barrier Precautions | respirator, gown, gloves, eye protection |
| Order to dress - sterile | gown, mask, googles, gloves |
| Order to undress - sterile | gloves, googles, gown, mask |
| brachytherapy | therapy at a short distance |
| brachytherapy applications | interstitial, intracavitary, intraluminal, intravascular, topical |
| prostate implants | Iodine-125, Palladium-103 |
| Eye plaque implants | Iodine-125 seeds |
| Mammosite | Iridium-192 |
| bradycardia | administer atropine |
| tachycardia | administer epinephrine |
| contrast reactions | 70% occur within the first 5 minutes of administration |
| 4 types of shock | septic, cardiogenic, neurogenic, hypovolemic |
| nasal cannula | when using below 6 L of O2 |
| simple face mask | 6 - 10 L O2 administered |
| non-rebreather mask | 12 - 15 L of O2/minutes |
| chest tube | 20 - 25 ml of fluid in the intrapleural space |
| ischemia | deficiency of blood due to functional constriction of blood vessels |
| ascites | accumulation of excess serous fluid in the abdomen |
| ecchymosis | small hemorrage spot in the skin forming a non-elevated, rounded or irregular blue/purplish patch |
| petecchia | pinpoint, non-raised, round purplish-red spots caused by intradermal hemorrhage |
| epitaxis | nosebleed |
| cachexia | general ill health and malnutrition |
| hyperalimentation | administration of more then optimal amount of nutrients |
| beriberi | deficiency of vitamin B1 |
| Leydig cells | cells of the testes that produce testosterone |
Created by:
Laura
Popular Nursing sets